Clinical Trials

Cancer Type

State

Phase

Treatment

Inhibitor

A Study of ZN-c3 in Patients With Ovarian Cancer

NCT 04516447 Brief Summary This is a Phase 1b open-label, multicenter study,…

Read more arrow_forward

A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies (ELM-2)

NCT 03888105 Brief Summary This study is researching an investigational drug, odronextamab,…

Read more arrow_forward

A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies

NCT 03557619 Brief Summary A study to assess the effect of multiple…

Read more arrow_forward

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

NCT 05503797 Brief Summary The objective of this Master Protocol is to…

Read more arrow_forward

A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors

NCT 05205109 Brief Summary This is a study of ATG-037 Monotherapy and…

Read more arrow_forward

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator’s Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer (rechARge)

NCT 06764485 Brief Summary The purpose of this study is to compare…

Read more arrow_forward

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

NCT 06065748 Brief Summary This is a Phase III, randomized, open-label multicenter…

Read more arrow_forward

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

NCT 05936359 Brief Summary This study is being conducted to evaluate…

Read more arrow_forward

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

NCT 04913285 Brief Summary The purpose of this study is to evaluate…

Read more arrow_forward

A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2) (SUCCESSOR-2)

NCT 05552976 Brief Summary The purpose of the study is to…

Read more arrow_forward

Knowledge Base

Cancer Types Cancer Services Health Professionals Clinical Trials

How we help you

Our support knows no limits, which means we do whatever it takes to be there for all you need.

How we help you View the Rare Cancer Support Guide

Can’t find what you’re looking for?

We have a friendly team available to chat about any questions you may have, or just to lend an ear if you’re having a tough time.

Call 1800 257 600 Have us call you